Monster Beverage Announces Webcast Details for Investor Meeting December 2, 2025; Company Announces Participation in Morgan Stanley Global Consumer & Retail Conference

(NASDAQ:MNST), CORONA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) announced today that its Chief Executive Officer, Hilton Schlosberg (the “CEO“), and members of its senior executive team will host an investor meeting Tuesday, December 2, 2025, to provide an update on the Company's business and operations. The Company's presentation will […]

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

(NASDAQ:CDTX), Target enrollment of 6,000 participants completed in the Northern Hemisphere Planned interim analysis in Q1 2026 will determine potential need for additional enrollment during Southern Hemisphere flu season SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC)

Hollister and Taco Bell Turn Y2K Nostalgia into the Season’s Spiciest Drop

(NYSE:ANF), NEW ALBANY, Ohio, Nov. 24, 2025 (GLOBE NEWSWIRE) — Hollister Co. (“Hollister”), a brand of Abercrombie & Fitch Co. (NYSE: ANF), and Taco Bell are heating up the holidays with a limited-edition collaboration that delivers equal parts cozy and nostalgic. Launching on Dec. 1, the Y2K-inspired capsule collection fuses Hollister's classic Feel Good Fleece

Iterum Therapeutics Provides Business Update

(NASDAQ:ITRM), DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now

HealthLynked Engages NE Holdings, LLC to Lead Strategic Advisory Services for Nasdaq Listing

(Other OTC:HLYK),(OTC US:HLYK), NAPLES, Fla., Nov. 24, 2025 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB:HLYK), a patient-centric healthcare technology company, announced today that it has entered into a Capital Market Advisory Agreement with NE Holdings, LLC, a Florida-based consulting firm specializing in senior exchange readiness and capital markets strategy. This engagement supports HealthLynked's

Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

(NASDAQ:SLNO), REDWOOD CITY, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th Healthcare Conference on Thursday, December 4, 2025,

Premier Aviation Corporation Hosts Full Tour for Rocco Mediate, Featuring Live Broadcast of The Rocco Hour

(PinkSheets:PREM),(Pinksheets:PREM), CARLSBAD, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier Air Charter,” “Premier,” “PAC,” or the “Company”) welcomed professional golfer and SiriusXM radio host Rocco Mediate for an exclusive tour of its facilities, where he met and spoke with team members across multiple departments. Widely celebrated for his

GigaCloud Technology Inc to Participate in UBS Global Technology and AI Conference

(NasdaqGM:GCT), EL MONTE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, it's Founder and Chief Executive Officer, and Erica Wei, its Chief Financial Officer, will conduct one-on-one meetings with investors

Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting

New findings from Phase 2 adjunctive study evaluating the characteristics of OFF time improvement with solengepras, a novel, non-dopaminergic GPR6 inhibitor; poster selected as one of 10 featured selections for the Poster Tour Results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for patients with early-stage Parkinson's disease to be presented BOSTON,

Kodak Unveils Smart Digital Frame Designed to Preserve Family Memories

HONG KONG, Nov. 24, 2025 (GLOBE NEWSWIRE) — Kodak proudly announces two flagship Wi-Fi smart digital frames — the 10.1-inch RWF-109V and the 14.1-inch RWF-141. More than just screens, they act as bridges between the cloud and real life, bringing photos from your phone and cloud storage back into your living space, displaying memories in

Scroll to Top